{"id":"https://openalex.org/W4394820159","doi":"https://doi.org/10.1177/13524585241242050","title":"Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS","display_name":"Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS","publication_year":2024,"publication_date":"2024-04-15","ids":{"openalex":"https://openalex.org/W4394820159","doi":"https://doi.org/10.1177/13524585241242050","pmid":"https://pubmed.ncbi.nlm.nih.gov/38619037","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11134969"},"language":"en","primary_location":{"id":"doi:10.1177/13524585241242050","doi":"https://doi.org/10.1177/13524585241242050","is_oa":true,"landing_page_url":"https://doi.org/10.1177/13524585241242050","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/13524585241242050?download=true","source":{"id":"https://openalex.org/S136332993","display_name":"Multiple Sclerosis Journal","issn_l":"1352-4585","issn":["1352-4585","1477-0970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://journals.sagepub.com/doi/pdf/10.1177/13524585241242050?download=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055725062","display_name":"Tanuja Chitnis","orcid":"https://orcid.org/0000-0002-9897-4422","observed_orcids":["https://orcid.org/0000-0002-9897-4422"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Tanuja Chitnis","raw_affiliation_strings":["Massachusetts General Hospital for Children, Boston, MA, USA"],"raw_orcid":"https://orcid.org/0000-0002-9897-4422","affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital for Children, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080221189","display_name":"Brenda Banwell","orcid":"https://orcid.org/0000-0001-6354-6770","observed_orcids":["https://orcid.org/0000-0001-6354-6770"]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"funder","lineage":["https://openalex.org/I1335321130"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brenda Banwell","raw_affiliation_strings":["Children\u2019s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I1335321130","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054874316","display_name":"Ludwig Kappos","orcid":"https://orcid.org/0000-0003-4175-5509","observed_orcids":["https://orcid.org/0000-0003-4175-5509"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]},{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ludwig Kappos","raw_affiliation_strings":["Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University of Basel, Basel, Switzerland/MS Center and Neurologic Clinic and Policlinic, Departments of Biomedicine and Clinical Research, University Hospital of Basel, Basel, Switzerland"],"raw_orcid":"https://orcid.org/0000-0003-4175-5509","affiliations":[{"raw_affiliation_string":"Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University of Basel, Basel, Switzerland/MS Center and Neurologic Clinic and Policlinic, Departments of Biomedicine and Clinical Research, University Hospital of Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I1850255","https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065754098","display_name":"Douglas Lorne Arnold","orcid":"https://orcid.org/0000-0003-4266-0106","observed_orcids":["https://orcid.org/0000-0003-4266-0106","https://orcid.org/0000-0002-0805-7672"]},"institutions":[{"id":"https://openalex.org/I4210133916","display_name":"NeuroRx Research (Canada)","ror":"https://ror.org/02r8axs93","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210133916"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Douglas L Arnold","raw_affiliation_strings":["Montreal Neurological Institute, McGill University, Montr\u00e9al, QC, Canada","NeuroRx Research, Montr\u00e9al, QC, Canada"],"raw_orcid":"https://orcid.org/0000-0003-4266-0106","affiliations":[{"raw_affiliation_string":"Montreal Neurological Institute, McGill University, Montr\u00e9al, QC, Canada","institution_ids":["https://openalex.org/I5023651"]},{"raw_affiliation_string":"NeuroRx Research, Montr\u00e9al, QC, Canada","institution_ids":["https://openalex.org/I4210133916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084955902","display_name":"K\u0131v\u0131lc\u0131m G\u00fcc\u00fcyener","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I95634034","display_name":"Gazi University","ror":"https://ror.org/054xkpr46","country_code":"TR","type":"education","lineage":["https://openalex.org/I95634034"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Kivilcim G\u00fcc\u00fcyener","raw_affiliation_strings":["Gazi Universitesi Tip Fakultesi Pediatrik N\u00f6roloji Bilim Dali, Ankara, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gazi Universitesi Tip Fakultesi Pediatrik N\u00f6roloji Bilim Dali, Ankara, Turkey","institution_ids":["https://openalex.org/I95634034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041774387","display_name":"Kumaran Deiva","orcid":"https://orcid.org/0000-0002-8409-2365","observed_orcids":["https://orcid.org/0000-0002-8409-2365"]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Kumaran Deiva","raw_affiliation_strings":["Department of Pediatric Neurology, Assistance Publique-H\u00f4pitaux de Paris, University Hospitals Paris Saclay, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Neurology, Assistance Publique-H\u00f4pitaux de Paris, University Hospitals Paris Saclay, Paris, France","institution_ids":["https://openalex.org/I4210097159"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043133942","display_name":"St\u00e9phane Saubadu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Stephane Saubadu","raw_affiliation_strings":["Sanofi, Chilly-Mazarin, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Chilly-Mazarin, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066528906","display_name":"Wenruo Hu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136746","display_name":"Sanofi (China)","ror":"https://ror.org/03pn9bd47","country_code":"CN","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210136746"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wenruo Hu","raw_affiliation_strings":["Sanofi, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Beijing, China","institution_ids":["https://openalex.org/I4210136746"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036189855","display_name":"Myriam B\u00e9namor","orcid":"https://orcid.org/0009-0004-2891-5779","observed_orcids":["https://orcid.org/0009-0004-2891-5779"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Myriam Benamor","raw_affiliation_strings":["Sanofi, Chilly-Mazarin, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Chilly-Mazarin, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055021609","display_name":"Annaig Le-Halpere","orcid":"https://orcid.org/0000-0002-9937-9916","observed_orcids":["https://orcid.org/0000-0002-9937-9916"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Annaig Le-Halpere","raw_affiliation_strings":["Sanofi, Chilly-Mazarin, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Chilly-Mazarin, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038386365","display_name":"Philippe Truffinet","orcid":"https://orcid.org/0000-0002-5895-9981","observed_orcids":["https://orcid.org/0000-0002-5895-9981"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe Truffinet","raw_affiliation_strings":["Sanofi, Chilly-Mazarin, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Chilly-Mazarin, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107840823","display_name":"Marc Tardieu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marc Tardieu","raw_affiliation_strings":["Department of Pediatric Neurology, Assistance Publique-H\u00f4pitaux de Paris, University Hospitals Paris Saclay, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Neurology, Assistance Publique-H\u00f4pitaux de Paris, University Hospitals Paris Saclay, Paris, France","institution_ids":["https://openalex.org/I4210097159"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5055725062"],"corresponding_institution_ids":["https://openalex.org/I4210087915"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":{"value":4200,"currency":"USD","value_usd":4200},"fwci":3.7582,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.94243859,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"30","issue":"7","first_page":"833","last_page":"842"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/teriflunomide","display_name":"teriflunomide","score":1.0},{"id":"https://openalex.org/keywords/pediatric-multiple-sclerosis","display_name":"pediatric multiple sclerosis","score":0.8610000014305115},{"id":"https://openalex.org/keywords/relapsing-multiple-sclerosis","display_name":"relapsing multiple sclerosis","score":0.9470000267028809},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.8989999890327454},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.7409999966621399},{"id":"https://openalex.org/keywords/gadolinium-enhancing-lesions","display_name":"gadolinium-enhancing lesions","score":0.9210000038146973},{"id":"https://openalex.org/keywords/t2-lesions","display_name":"T2 lesions","score":0.7699999809265137},{"id":"https://openalex.org/keywords/disability-progression","display_name":"disability progression","score":0.9800000190734863},{"id":"https://openalex.org/keywords/pancreatitis","display_name":"pancreatitis","score":0.8450000286102295},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.7179999947547913},{"id":"https://openalex.org/keywords/long-term-treatment","display_name":"long-term treatment","score":0.7229999899864197}],"concepts":[{"id":"https://openalex.org/C2777703276","wikidata":"https://www.wikidata.org/wiki/Q3077133","display_name":"Teriflunomide","level":4,"score":0.9956393241882324},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7807611227035522},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.685368537902832},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6278023719787598},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49601349234580994},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.4737732410430908},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3465011417865753},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.11449328064918518},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.113231360912323},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.05790066719055176},{"id":"https://openalex.org/C2776036978","wikidata":"https://www.wikidata.org/wiki/Q425137","display_name":"Fingolimod","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003437","descriptor_name":"Crotonates","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003437","descriptor_name":"Crotonates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006885","descriptor_name":"Hydroxybutyrates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008279","descriptor_name":"Magnetic Resonance Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014052","descriptor_name":"Toluidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014052","descriptor_name":"Toluidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014052","descriptor_name":"Toluidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014052","descriptor_name":"Toluidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1177/13524585241242050","doi":"https://doi.org/10.1177/13524585241242050","is_oa":true,"landing_page_url":"https://doi.org/10.1177/13524585241242050","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/13524585241242050?download=true","source":{"id":"https://openalex.org/S136332993","display_name":"Multiple Sclerosis Journal","issn_l":"1352-4585","issn":["1352-4585","1477-0970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis Journal","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11134969","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11134969","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11134969/pdf/10.1177_13524585241242050.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mult Scler","raw_type":"Text"},{"id":"pmid:38619037","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38619037","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple sclerosis (Houndmills, Basingstoke, England)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1177/13524585241242050","doi":"https://doi.org/10.1177/13524585241242050","is_oa":true,"landing_page_url":"https://doi.org/10.1177/13524585241242050","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/13524585241242050?download=true","source":{"id":"https://openalex.org/S136332993","display_name":"Multiple Sclerosis Journal","issn_l":"1352-4585","issn":["1352-4585","1477-0970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4394820159.pdf","grobid_xml":"https://content.openalex.org/works/W4394820159.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W2001956066","https://openalex.org/W2010972355","https://openalex.org/W2021506523","https://openalex.org/W2036863084","https://openalex.org/W2043591841","https://openalex.org/W2059131090","https://openalex.org/W2064775943","https://openalex.org/W2070362842","https://openalex.org/W2095116045","https://openalex.org/W2096479500","https://openalex.org/W2107852678","https://openalex.org/W2122999365","https://openalex.org/W2131078277","https://openalex.org/W2133329597","https://openalex.org/W2195362151","https://openalex.org/W2272606123","https://openalex.org/W2512396757","https://openalex.org/W2790072792","https://openalex.org/W2890515892","https://openalex.org/W2945360219","https://openalex.org/W3020868801","https://openalex.org/W3211389104","https://openalex.org/W4200241961","https://openalex.org/W4240233136","https://openalex.org/W4297460551","https://openalex.org/W4312055650"],"related_works":["https://openalex.org/W3211389104","https://openalex.org/W2791646516","https://openalex.org/W4292623595","https://openalex.org/W2025098728","https://openalex.org/W3212047167","https://openalex.org/W1538626930","https://openalex.org/W2161146350","https://openalex.org/W2064775943","https://openalex.org/W2131078277","https://openalex.org/W2022100073"],"abstract_inverted_index":{"Background:":[0],"The":[1,65],"double-blind":[2,32,134],"TERIKIDS":[3,26],"study":[4],"demonstrated":[5],"the":[6,15,25,31,61,132,160,180,186],"efficacy":[7,207],"and":[8,18,97,102,120,135,170,197],"safety":[9,200],"of":[10,20,99,145,164,189],"teriflunomide.":[11],"Objective:":[12],"To":[13],"evaluate":[14],"efficacy,":[16],"safety,":[17],"tolerability":[19,196],"continuous":[21],"teriflunomide":[22,43,54],"treatment":[23],"in":[24,60,131,179],"open-label":[27,62,136,161],"extension.":[28,63],"Methods:":[29],"In":[30],"period,":[33],"children":[34,175],"with":[35,193],"relapsing":[36],"MS":[37],"were":[38,106,167],"randomized":[39],"to":[40],"placebo":[41],"or":[42],"(14":[44],"mg":[45],"adult-equivalent":[46],"dose)":[47],"for":[48,55,150],"\u2a7d":[49,56],"96":[50],"weeks.":[51],"Participants":[52],"received":[53],"192":[57],"weeks":[58],"post-randomization":[59],"Results:":[64],"mean":[66],"age":[67],"at":[68],"screening":[69],"was":[70,81,139],"14.6":[71],"years.":[72],"For":[73],"teriflunomide/teriflunomide":[74,151,181],"versus":[75,152],"placebo/teriflunomide,":[76],"estimated":[77],"clinical":[78,206],"relapse":[79],"risk":[80,111,144,188],"reduced":[82,107,143,185],"by":[83,108],"38%":[84],"(hazard":[85],"ratio":[86],"(HR)":[87],"0.62;":[88],"95%":[89,114,124,156],"confidence":[90],"interval":[91],"(CI)":[92],"0.39\u20130.98;":[93],"p":[94,117,127],"=":[95,118,128],"0.11)":[96],"numbers":[98],"gadolinium-enhancing":[100],"T1":[101],"new/enlarging":[103],"T2":[104],"lesions":[105],"43%":[109],"(relative":[110],"(RR)":[112],"0.570;":[113],"CI":[115,125,157],"0.33\u20130.98;":[116],"0.043)":[119],"49%":[121],"(RR":[122],"0.511;":[123],"0.34\u20130.76;":[126],"0.001),":[129],"respectively,":[130],"combined":[133],"periods.":[137],"There":[138],"a":[140],"trend":[141],"toward":[142],"24-week":[146],"sustained":[147],"disability":[148],"progression":[149],"placebo/teriflunomide":[153],"(HR":[154],"0.47;":[155],"0.23\u20130.96).":[158],"During":[159],"extension,":[162],"incidences":[163],"safety-related":[165],"discontinuations":[166],"4.0%":[168],"(teriflunomide/teriflunomide)":[169],"13.5%":[171],"(placebo/teriflunomide),":[172],"including":[173],"two":[174],"who":[176],"developed":[177],"pancreatitis":[178],"group.":[182],"Conclusion:":[183],"Teriflunomide":[184],"long-term":[187],"focal":[190],"inflammatory":[191],"activity,":[192],"generally":[194],"manageable":[195],"no":[198],"new":[199],"signals.":[201],"Further":[202],"evidence":[203],"would":[204],"strengthen":[205],"findings.":[208],"ClinicalTrials.gov:":[209],"NCT02201108.":[210]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-04-16T00:00:00"}